(Q55467801)

English

A phase 2 feasibility study of sequential, dose intensive chemotherapy to treat progressive low-grade gliomas in children.

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17805033

retrieved

12 July 2018

reference URL

http://europepmc.org/abstract/MED/17805033

title

A phase 2 feasibility study of sequential, dose intensive chemotherapy to treat progressive low-grade gliomas in children. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17805033

retrieved

12 July 2018

reference URL

http://europepmc.org/abstract/MED/17805033

1 reference

Carol S Bruggers

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17805033

retrieved

12 July 2018

reference URL

http://europepmc.org/abstract/MED/17805033

Dayna Greene

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17805033

retrieved

12 July 2018

reference URL

http://europepmc.org/abstract/MED/17805033

publication date

1 September 2007

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17805033

retrieved

12 July 2018

reference URL

http://europepmc.org/abstract/MED/17805033

published in

Journal of Pediatric Hematology/Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17805033

retrieved

12 July 2018

reference URL

http://europepmc.org/abstract/MED/17805033

volume

29

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17805033

retrieved

12 July 2018

reference URL

http://europepmc.org/abstract/MED/17805033

issue

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17805033

retrieved

12 July 2018

reference URL

http://europepmc.org/abstract/MED/17805033

page(s)

602-607

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17805033

retrieved

12 July 2018

reference URL

http://europepmc.org/abstract/MED/17805033

cites work

Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1200/JCO.1995.13.8.2072

Identifiers

DOI

10.1097/MPH.0B013E318142B585

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17805033

retrieved

12 July 2018

reference URL

http://europepmc.org/abstract/MED/17805033

PubMed publication ID

17805033

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17805033

retrieved

12 July 2018

reference URL

http://europepmc.org/abstract/MED/17805033

(Q55467801)

A phase 2 feasibility study of sequential, dose intensive chemotherapy to treat progressive low-grade gliomas in children.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)